These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25583248)

  • 1. Predictors of neuropsychological effort test performance in schizophrenia.
    Morra LF; Gold JM; Sullivan SK; Strauss GP
    Schizophr Res; 2015 Mar; 162(1-3):205-10. PubMed ID: 25583248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder.
    Chianetta JM; Lefebvre M; LeBlanc R; Grignon S
    Schizophr Res; 2008 Oct; 105(1-3):86-94. PubMed ID: 18790606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia.
    Wilk CM; Gold JM; Bartko JJ; Dickerson F; Fenton WS; Knable M; Randolph C; Buchanan RW
    Am J Psychiatry; 2002 May; 159(5):838-44. PubMed ID: 11986139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity.
    Gold JM; Queern C; Iannone VN; Buchanan RW
    Am J Psychiatry; 1999 Dec; 156(12):1944-50. PubMed ID: 10588409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings.
    Loughland CM; Lewin TJ; Carr VJ; Sheedy J; Harris AW
    Schizophr Res; 2007 Jan; 89(1-3):232-42. PubMed ID: 17049816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study.
    Peña J; Segarra R; Ojeda N; García J; Eguiluz JI; Gutiérrez M
    J Psychiatr Res; 2012 Jun; 46(6):774-81. PubMed ID: 22487311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia.
    Wang MY; Ho NF; Sum MY; Collinson SL; Sim K
    Schizophr Res; 2016 Aug; 175(1-3):97-102. PubMed ID: 27146474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of insufficient cognitive effort in schizophrenia in light of low IQ scores.
    Whearty KM; Allen DN; Lee BG; Strauss GP
    J Psychiatr Res; 2015 Sep; 68():397-404. PubMed ID: 26026486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validity of the Repeatable Battery for the Assessment of Neuropsychological Status among patients with schizophrenia in the Republic of Armenia.
    Azizian A; Yeghiyan M; Ishkhanyan B; Manukyan Y; Khandanyan L
    Arch Clin Neuropsychol; 2011 Mar; 26(2):89-97. PubMed ID: 21177761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motivated to do well: an examination of the relationships between motivation, effort, and cognitive performance in schizophrenia.
    Foussias G; Siddiqui I; Fervaha G; Mann S; McDonald K; Agid O; Zakzanis KK; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):276-82. PubMed ID: 26008882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the repeatable battery for the assessment of neuropsychological status (RBANS) effort index to predict treatment group attendance in patients with schizophrenia.
    Moore RC; Davine T; Harmell AL; Cardenas V; Palmer BW; Mausbach BT
    J Int Neuropsychol Soc; 2013 Feb; 19(2):198-205. PubMed ID: 23234753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of cognitive impairment with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in adolescents with psychotic symptomatology.
    Holzer L; Chinet L; Jaugey L; Plancherel B; Sofia C; Halfon O; Randolph C
    Schizophr Res; 2007 Sep; 95(1-3):48-53. PubMed ID: 17629676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors.
    Dickerson F; Schroeder J; Stallings C; Origoni A; Katsafanas E; Schwienfurth LA; Savage CL; Khushalani S; Yolken R
    Schizophr Res; 2014 Jul; 156(2-3):248-53. PubMed ID: 24827555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the Audio Recorded Cognitive Screen and its relation to functioning in schizophrenia.
    Gelder BM; Loughland CM; Carr VJ; Schofield PW
    Acta Neuropsychiatr; 2015 Oct; 27(5):279-90. PubMed ID: 25959604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior intellectual ability in schizophrenia: neuropsychological characteristics.
    MacCabe JH; Brébion G; Reichenberg A; Ganguly T; McKenna PJ; Murray RM; David AS
    Neuropsychology; 2012 Mar; 26(2):181-90. PubMed ID: 22201301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.